| Old Articles: <Older 19521-19530 Newer> |
|---|
 |
The Motley Fool
January 2, 2007
Rick Aristotle Munarriz |
4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Atlantic Coast Federal... First of Long Island... York Water... First United...   |
The Motley Fool
January 2, 2007
Rick Aristotle Munarriz |
3 Stocks That Blew the Market Away Beat the market, and the world will beat a path to your door. Apple Computer... Google... Global Payments... |
The Motley Fool
January 2, 2007
Rich Duprey |
Foolish Forecast: A Polished Alcoa With the aluminum company trading at a 20% discount to its historical price-to-sales ratio for the past 10 years, and at some of its lowest levels in the past five, Alcoa could be poised for yet another sterling run. |
The Motley Fool
January 2, 2007
Rick Aristotle Munarriz |
Play It Again, Sam Walton Despite a disappointing November that found comps sliding by 0.1%, the world's largest retailer bounced back during the critical holiday shopping season, posting a 1.6% uptick in same-store sales for the month of December. |
The Motley Fool
January 2, 2007
Rich Duprey |
Foolish Forecast: Monsanto Blooms What will crop up in the agricultural behemoth's first-quarter 2007 earnings? |
The Motley Fool
January 2, 2007
Ryan Fuhrmann |
Foolish Face-Off: Home-Improvement Giants One of the biggest questions on investors' minds is what will happen to the homebuilding market in 2007. Home Depot wins the face-off, with three wins to Lowe's two, but the best strategy may be to consider a weighting in both. |
The Motley Fool
January 2, 2007
Rich Duprey |
Foolish Forecast: Topps Not on Top The trading card company reports its third-quarter 2007 results shortly, and right now, they don't look too sweet. Investors, take note. |
The Motley Fool
January 2, 2007
Rich Duprey |
Apple's Rotting Core? Although the computer maker absolved its CEO of wrongdoing, should investors be so lenient? |
The Motley Fool
December 29, 2006
Ryan Fuhrmann |
Marsh Mac Punts Putnam The Putnam saga looks to be ending soon for financial and business services firm Marsh & McLennan. It won't be the most graceful exit, but it should allow the company to put its past struggles behind it once and for all. Investors, take note. |
The Motley Fool
December 29, 2006
Brian Lawler |
Is Threshold on the Verge of Success? Shares of Threshold Pharmaceuticals were the second-best performer on the market yesterday, up 28% as a result of positive phase 2 clinical trial results for its lead drug, glufosfamide. |
| <Older 19521-19530 Newer> Return to current articles. |
